Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis
© Derengowski et al; licensee BioMed Central Ltd. 2009
Received: 06 October 2008
Accepted: 29 April 2009
Published: 29 April 2009
Farnesol is a sesquiterpene alcohol produced by many organisms, and also found in several essential oils. Its role as a quorum sensing molecule and as a virulence factor of Candida albicans has been well described. Studies revealed that farnesol affect the growth of a number of bacteria and fungi, pointing to a potential role as an antimicrobial agent.
Growth assays of Paracoccidioides brasiliensis cells incubated in the presence of different concentrations of farnesol were performed by measuring the optical density of the cultures. The viability of fungal cells was determined by MTT assay and by counting the colony forming units, after each farnesol treatment. The effects of farnesol on P. brasiliensis dimorphism were also evaluated by optical microscopy. The ultrastructural morphology of farnesol-treated P. brasiliensis yeast cells was evaluated by transmission and scanning electron microscopy.
In this study, the effects of farnesol on Paracoccidioides brasiliensis growth and dimorphism were described. Concentrations of this isoprenoid ranging from 25 to 300 μM strongly inhibited P. brasiliensis growth. We have estimated that the MIC of farnesol for P. brasiliensis is 25 μM, while the MLC is around 30 μM. When employing levels which don't compromise cell viability (5 to 15 μM), it was shown that farnesol also affected the morphogenesis of this fungus. We observed about 60% of inhibition in hyphal development following P. brasiliensis yeast cells treatment with 15 μM of farnesol for 48 h. At these farnesol concentrations we also observed a significant hyphal shortening. Electron microscopy experiments showed that, despite of a remaining intact cell wall, P. brasiliensis cells treated with farnesol concentrations above 25 μM exhibited a fully cytoplasmic degeneration.
Our data indicate that farnesol acts as a potent antimicrobial agent against P. brasiliensis. The fungicide activity of farnesol against this pathogen is probably associated to cytoplasmic degeneration. In concentrations that do not affect fungal viability, farnesol retards the germ-tube formation of P. brasiliensis, suggesting that the morphogenesis of this fungal is controlled by environmental conditions.
Essential oils are complex mixes of hydrophobic liquids containing volatile aromatic compounds, which are products of plant secondary metabolism . Of all the claimed properties of essential oils, its antimicrobial activity is the one which receives special attention due to the serious threat that antibiotic resistance has become. Therefore, the study of potential antibiotic compounds found in these oils could be of interest in the development of novel antimicrobial agents.
Farnesol is a sesquiterpene alcohol present in many essential oils – e.g. from Pluchea dioscoridis, Zea mays and Pittosporum undulatum, possibly protecting these plants from parasitic induced damages [2–4]. Recently, this sesquiterpene alcohol has been demonstrated to inhibit the growth of some microorganisms, such as the human pathogens Staphylococcus aureus [5, 6] and Streptococcus mutans , and the plant pathogenic fungus Fusarium graminearum , signaling its potential use as an antimicrobial agent. Farnesol also enhances microbial susceptibility to antibiotics, indicating a putative application as an adjuvant therapeutic agent [9, 10]. Although its mechanism of action is not fully understood, it probably involves cell membrane damages and impaired ergosterol synthesis .
This sesquiterpenoid was also identified as a quorum-sensing molecule produced by the dimorphic fungus Candida albicans, where it prevents the fungal transition from yeast to mycelium, and disrupts biofilm formation [11, 12]. C. albicans synthesizes farnesol from farnesyl pyrophosphate (FPP), a well known intermediate of the highly conserved sterol biosynthetic pathway . A recent study showed that farnesol increases the virulence of C. albicans in a mouse infection model . In another work, it appears that farnesol is employed by C. albicans in order to reduce competition with other microbes, since this compound mediated apoptosis in the filamentous fungus Aspergillus nidulans , and inhibited biofilm formation in other Candida species [10, 16].
In this study, we tested the effects of farnesol on Paracoccidioides brasiliensis growth and morphogenesis. P. brasiliensis is the etiologic agent of paracoccidioidomycosis (PCM), a systemic human mycosis geographically confined to Latin America [17, 18]. This organism is a thermal dimorphic fungus, which can be found as mycelium at room temperature (25°C) and as yeast cells at body temperature (37°C). Although little is known about the ecology of this fungus, it is thought that infection occurs when the mycelial form releases conidia or hyphal fragments to the environment and, upon inhalation by the host, these structures differentiate to the yeast form . This dimorphic transition of mycelium to yeast phase seems to be essential to the establishment of the infective process . In this context, our results revealed that farnesol reduces the viability of this pathogen and delays the dimorphism, suggesting an antimicrobial activity against P. brasiliensis, probably due the massive cytoplasmic organelles degeneration.
Yeast cells of the virulent isolate 18 of P. brasiliensis (Pb18) were maintained by weekly passages in semi-solid Fava Neto's medium (0.3% protease peptone, 1% peptone, 0.5% beef extract, 0.5% yeast extract, 4% glucose, 0.5% NaCl, 1.6% agar, pH 7.2) at 36°C, and were used after 6 – 9 days of growth. The fungal cells used in all experiments were suspended in complex medium YPD (yeast-peptone-dextrose), vigorously vortexed and counted in a Neubauer chamber. The cell viability was determined by vital Janus green stain . C. albicans ATCC 10231, used as a control, was also maintained on semi-solid Fava Neto's medium at 36°C and transferred at regular intervals. Under these conditions over 95% of C. albicans cells remained in the yeast form.
P. brasiliensis growth assay upon farnesol treatment
In all assays, a mixture of stereoisomers of farnesol (assay ≥ 90%; GS, sum of isomers; Fluka, Sigma-Aldrich) was diluted in 100% methanol. Working concentrations were prepared in YPD medium.
For the in vitro growth assay, 2 × 105 P. brasiliensis yeast cells per mL were inoculated in complex medium YPD supplemented with farnesol at different final concentrations (5, 10, 25, 50, 100, 150 and 300 μM), employing 96 well-plates in a final volume of 200 μL. Farnesol-free controls were supplemented with 2% methanol, the farnesol diluent. Cultures were allowed to grow at 36°C for 25 days. The number of cells at each specific time interval was determined by measuring the OD absorption at 630 nm of vigorously vortexed cultures. The growth curve of each culture was prepared by plotting the logarithmic values of OD630 vs. incubation time. All experiments were carried out in triplicate. The Minimum Inhibitory Concentration (MIC) for farnesol was defined as the lowest concentration that resulted in 90% of inhibition of cell growth when compared to the farnesol-free control cells.
Effect of farnesol on P. brasiliensis cell viability
The analysis of cell viability was performed using the tetrazolium salt 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT; Sigma) in a colorimetric assay that measures mitochondrial activity. To determine the MLC (Minimal Lethal Concentration) of farnesol for P. brasiliensis, 2 × 105 yeast cells/mL were incubated in YPD medium with farnesol at the final concentrations of 2.5, 5, 7.5, 10, 12.5, 15, 17.5, 20, 22.5, 25, 27.5, 30, 50, 75, 100, 150 and 300 μM. After 15 days of incubation with different concentrations of farnesol at 36°C (150 rpm) in 96-well tissue culture plates, a solution containing 5 mg of MTT per mL of 0.15 M phosphate-buffered saline (PBS) was added to each well to reach a final concentration of 0.5 mg/mL. After incubation for 4 h at 36°C, the medium containing MTT was partially removed, and dimethyl sulfoxide (100 μL) was added to solubilize the MTT formazan product. MTT formazan formation was measured at 490 nm by using a spectrophotometer. Control wells contained medium plus MTT to determine background formazan values. All assays were done in triplicate. The MLC for farnesol was defined as the lowest concentration that resulted in 90% of cell death when compared to the farnesol-free control cells.
The effect of farnesol on cell viability was also estimated by colony counting. Yeast cells of P. brasiliensis were suspended in YPD medium at a density of 2 × 105 cells/mL, and farnesol was added to final concentrations of 5, 10, 25, 50 and 100 μM. Farnesol-free controls were supplemented with 2% methanol. After incubation at 36°C for 4 days in an orbital shaker (150 rpm), cells were harvested by centrifugation (4000 × g/5 min), washed and plated on brain heart infusion agar (BHI) supplemented with 4% fetal calf serum (FCS), for at least 12 days to determine their viability, expressed as colony forming units (CFU). The survival rate of these cultures was compared to farnesol-free cultures. The number of single colonies on each plate was counted and the percentage of cell killing calculated as (1 - N1/N2) × 100, where N1 is the mean of the number of colonies from farnesol-treated P. brasiliensis cells, and N2 is the mean of the number of colonies from P. brasiliensis non-treated cells. The experiments were carried out in triplicate.
Effect of farnesol on P. brasiliensis dimorphic transition
To evaluate the effects of farnesol on P. brasiliensis dimorphism, 2 × 105 yeast cells/mL were inoculated in YPD medium and farnesol was added to final concentrations of 5, 7.5, 10, 15, 20 and 25 μM. Cultures were incubated for 48 h at 25°C in an orbital shaker (150 rpm). Farnesol-free controls were supplemented with 2% methanol, the farnesol diluent. Cell morphology was assessed by light microscopy. The percentage of cells showing germ-tubes after 24 h and 48 h of incubation was calculated. Additionally, the average size of the germ tubes was measured after the same period of time. All experiments were carried out in triplicate. The P. brasiliensis dimorphism from mycelium to yeast cells was also evaluated by the treatment of the mycelial form with farnesol at different final concentrations (5, 10, and 25 μM), for 4 days at 36°C, following exactly the same conditions described above for the transition in the opposite direction.
Transmission and Scanning electron microscopy
Transmission electron microscopy (TEM) was performed according to the following standard procedure. Briefly, P. brasiliensis yeast cells were cultivated at 36°C for 3 days in YPD medium without (control supplemented with 2% methanol) or with farnesol (25, 50 and 150 μM). Cells were harvested by centrifugation at 4000 × g for 5 min, washed four times with phosphate-buffered saline (PBS, pH 7.2) and fixed overnight at 4°C (2% glutaraldehyde, 2% paraformaldehyde in 0.1 M sodium cacodylate buffer, pH 7.2, with 3% sucrose and 3 mM CaCl2). After fixation, cells were harvested by centrifugation (4000 × g/5 min), and the pellet was washed four times in 0.1 M sodium cacodylate buffer (4000 × g/15 min). Samples were post-fixed for 1 hour (1% osmium tetroxide, 0.8% potassium ferrocyanide in the same buffer), contrasted en bloc with 0.5% uranyl acetate, dehydrated through an ascending acetone series and embedded in Spurr resin. The ultrathin sections were contrasted with uranyl acetate/lead citrate and observed in a TEM Jeol 1011 at 80 kV.
In order to prepare samples to scanning electron microscopy analysis, P. brasiliensis yeast cells treated with different concentrations of farnesol (25 and 50 μM) for 5, 10 and 24 h, were fixed overnight at 4°C (2% glutaraldehyde, 2% paraformaldehyde in 0.1 M sodium cacodylate buffer, pH 7.2, with 3% sucrose and 3 mM CaCl2), harvested by centrifugation (4000 × g/5 min), and the pellet was washed four times in 0.1 M sodium cacodylate buffer (4000 × g/15 min). Samples were post-fixed for 1 hour (1% osmium tetroxide, 0.8% potassium ferrocyanide in the same buffer), and then applied on a polylysine-coated coverslip and serially dehydrated in acetone. The samples were dried in a critical point drier (BAL-TEC CPD-030 – Electron Microscopy Sciences, USA), coated with gold-palladium (Balzers Union SCD-040 – Electron Microscopy Sciences, USA) and viewed using a JEOL (Tokyo, Japan) JEM 840A electron microscope.
Statistical analyses were performed using the software "Mynova", verson 1.3 (S. Brooks, Copyright 1993). The statistical test applied was Student's t test. A P value ≤ 0.001 was considered significant.
Results and discussion
Farnesol affects P. brasiliensis growth and viability
The incidence of fungal infections has dramatically increased in the last two decades [22, 23]. Simultaneously, the resistance to antifungal agents has become an important problem in several fungal diseases. In addition to the drug resistance problem, the current antifungal therapies are limited due the high toxicity of the agents and their low efficacy rates .
PCM is commonly treated with sulfonamides, azoles and amphotericin B . In spite of the good efficacy of these antifungal agents against P. brasiliensis, some of these compounds, like amphotericin B, can also damage the host cells . Furthermore, Hanh et al.  described the occurrence of ketoconazole resistant isolates of P. brasiliensis in PCM patients. The P. brasiliensis transcriptome analysis revealed several ortholog genes related to transmembrane proteins that can function as efflux pumps . The existence of such genes augurs the possible emergency of resistant isolates, emphasizing the importance of novel antimicrobial agent development.
In this context, the interest in studying the antimicrobial activity of plant extracts and essential oils has increased in recent years. San-Blas et al.  demonstrated that ajoene, a compound from Allium sativum, inhibits the growth of P. brasiliensis. These authors suggested that the integrity of the fungal cytoplasmic membrane could probably be the target of this garlic-derived compound, since ajoene promotes changes in the phospholipid and fatty acid proportions . Furthermore, the association of ajoene and chemotherapeutic drugs show a positive additive effect in the treatment of mice infected with P. brasiliensis .
In this work we evaluated the role of farnesol, a sesquiterpene alcohol present in many essential oils [2–4, 32], and also produced as a quorum sensing molecule by C. albicans, in P. brasiliensis growth and morphogenesis.
In order to evaluate if the effects of farnesol on P. brasiliensis growth were caused by an increase in mortality, a viability assay based on metabolism (Figure 1B) was performed (MTT assay). This test showed that the percentage of non-viable fungal cells increased proportionally with farnesol concentrations, suggesting that farnesol has a potent fungicide activity against P. brasiliensis. The same behavior of farnesol on P. brasiliensis viability was observed when we performed experiments based on CFU counts (data not shown). The Figure 1A reveals that farnesol concentrations of 25 μM or higher have an inhibitory effect on P. brasiliensis growth, while P. brasiliensis metabolism completely ceased at the farnesol concentration of 30 μM (Figure 1B). According to these data we have determined that the MIC of farnesol for P. brasiliensis is 25 μM, while the MLC is 30 μM.
This role of farnesol in the inhibition of P. brasiliensis growth and viability has also been verified in other microorganisms [6–8, 33–36], suggesting that this compound also possess an effective antimicrobial activity against P. brasiliensis. Interestingly, our data indicate that P. brasiliensis is more sensitive to farnesol than other pathogens since, while for P. brasiliensis the MLC corresponds to 30 μM, the MLC is of 200 μM for the bacteria S. aureus and Streptomyces tendae [6, 33]. The bacterium S. mutans and the fungus Candida dubliniensis show higher tolerances to farnesol, with an MLC of 300 μM and 500 μM, respectively [7, 10].
Farnesol delays the dimorphic transition of P. brasiliensis
Similar results were observed with C. albicans cells, where farnesol also prevented germ tubes formation [11, 37]. Other studies revealed that farnesol is also employed by C. albicans to mediate antagonistic interactions with other microorganisms [10, 15, 16]. Semighini et al.  showed that exogenous farnesol triggers apoptosis in the filamentous fungus A. nidulans. Moreover, the possibility that farnesol produced by C. albicans might affect A. nidulans was evaluated in a co-culture model, showing that the co-cultivation inhibits the growth of A. nidulans in a farnesol-dependent manner . A recent work reported that the addition of farnesol to cultures of Pseudomonas aeruginosa leads to a decrease in the amount of Pseudomonas quinolone signal (PQS), and of the virulence factor pyocyanin produced by this pathogen. In addition, pyocyanin and PQS levels in P. aeruginosa-C. albicans co-cultures were reduced to 42.1% relative to a control pure culture of P. aeruginosa. A similar decrease was verified in farnesol-treated P. aeruginosa cultures, suggesting that farnesol may be involved in inter-kingdom interactions .
Noteworthy was the inhibition of P. brasiliensis hyphal development when yeast cells were grown on a conditioned medium (CM), which corresponds to the filtered supernatant of a high-density C. albicans culture added to a conventional culture medium (data not shown). This result suggests that P. brasiliensis germ tube formation could be controlled by a soluble factor present in the C. albicans culture supernatant . In this sense, we propose that the farnesol-mediated communication between C. albicans and other microorganisms is probably not species-specific.
Curiously, tyrosol, another compound also identified as a quorum-sensing molecule produced by C. albicans , did not affect either P. brasiliensis growth or morphogenesis at concentrations up to 300 μM (data not shown).
Ultrastructural morphology analysis of P. brasiliensis yeast cells treated with farnesol
Although the role of farnesol as a potential antimicrobial agent has been determined in this work, its mode of action is not understood. Some studies have indicated a possible interaction of farnesol with cell membranes of certain microorganisms, including the bacteria S. mutans, S. aureus and E. coli, [5–7, 9, 41], and the fungi C. albicans and C. dubliniensis . A hypothesis is that the hydrophobic property of farnesol favors its accumulation in the membrane, causing membrane disruption .
In contrast, yeast cells treated with increasing concentrations of farnesol exhibited extensive cytoplasmic organelles damages. Remarkable changes, resulting in overall degeneration of internal structures, were found in P. brasiliensis cells cultivated in the presence of 25, 50 and 100 μM of farnesol (Figure 4B–D). Various stages of degradation were observed, ranging from cells with partially digested cytoplasmic organelles, to cells with only the cell wall remaining intact (Figure 4D). These results suggest that death is probably associated to the disruption of cytoplasmic structures and internal cellular disintegration.
Scanning electron microscopy was also performed employing P. brasiliensis yeast cells treated with farnesol, as described in material and methods. Cells treated with different concentrations of farnesol showed no major differences at their surfaces when compared to the control cells incubated without farnesol. Figure 4E shows the scanning electron micrograph of the 50 μM farnesol-treated yeast cells of P. brasiliensis, revealing an intact fungal cell. This result corroborates the data obtained by transmission electron microscopy, suggesting that farnesol does not affect the cell wall structure.
Similar results were reported by San-Blas et al.  studying the antifungal activity of ajoene, which blocks the growth of P. brasiliensis by inhibiting phosphatidylcholine synthesis . Curiously, farnesol induces apoptosis in tumorigenic cells by a similar mode of action [42, 43], suggesting an antiproliferative mechanism shared by ajoene and farnesol.
Moreover, our findings show that the fungicidal mechanism of farnesol is probably associated to the disruption of all cytoplasmic cellular organelles. A similar cytoplasm disintegration also occurs after the ingestion of P. brasiliensis yeast cells by cytokine-activated murine macrophages , indicating that this is possibly a common event in response to a stress condition.
In order to understand the mode of action of farnesol on P. brasiliensis, a microarray large scale analysis of gene expression, as well as assays to evaluate the cell death pathway activated in response to farnesol, should be performed. Of major interest is the analysis of the expression of genes related to phospholid and sterol synthesis pathways, as well and those related to the apoptotic process, which are in progress.
In summary, our data indicate that farnesol acts as a potent antimicrobial agent against P. brasiliensis, which is very sensitive to this sesquiterpene alcohol. The fungicide activity of farnesol in this pathogen is probably associated to cytoplasmic degeneration, in spite of the apparent cell wall integrity, as observed by transmission and scanning electron micrographs. Although the antimicrobial activity of farnesol has been clearly shown, additional studies involving animal models need to be performed to assess the potential effects of farnesol in vivo. It must be emphasized that the toxicity of exogenously administrated farnesol on mice is negligible, as shown by Navarathna et al. . Besides the observation of no significant gross changes in control and treated mice examined at necropsy, these authors verified that the oral (20 mM in water) or intraperitoneal (1 ml of 20 mM) administration of farnesol was harmless to mice, since there were no differences in weight or water ingestion between control and farnesol-treated animals.
In this sense, the antagonistic property of farnesol against P. brasiliensis cells is particularly interesting, since it could be further explored in order to evaluate its possible use as an antimicrobial agent.
This work was supported by CNPq, FAP-DF and FINEP. LSD was supported by a fellowship from CNPq.
- Prabuseenivasan S, Jayakumar M, Ignacimuthu S: In vitro antibacterial activity of some plant essential oils. BMC Complement Altern Med. 2006, 30 (6): 39-10.1186/1472-6882-6-39.View ArticleGoogle Scholar
- Grace MH: Chemical composition and biological activity of the volatiles of Anthemis melampodina and Pluchea dioscoridis. Phytother Res. 2002, 16 (2): 183-5. 10.1002/ptr.872View ArticlePubMedGoogle Scholar
- Medeiros JR, Campos LB, Mendonça SC, Davin LB, Lewis NG: Composition and antimicrobial activity of the essential oils from invasive species of the Azores, Hedychium gardnerianum and Pittosporum undulatum. Phytochemistry. 2003, 64 (2): 561-5. 10.1016/S0031-9422(03)00338-8View ArticlePubMedGoogle Scholar
- Schnee C, Köllner TG, Gershenzon J, Degenhardt J: The maize gene terpene synthase 1 encodes a sesquiterpene synthase catalyzing the formation of (E)-beta-farnesene, (E)-nerolidol, and (E, E)-farnesol after herbivore damage. Plant Physiol. 2002, 130 (4): 2049-60. 10.1104/pp.008326PubMed CentralView ArticlePubMedGoogle Scholar
- Inoue Y, Shiraishi A, Hada T, Hirose K, Hamashima H, Shimada J: The antibacterial effects of terpene alcohols on Staphylococcus aureus and their mode of action. FEMS Microbiol Lett. 2004, 237 (2): 325-31.PubMedGoogle Scholar
- Jabra-Rizk MA, Meiller TF, James CE, Shirtliff ME: Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob Agents Chemother. 2006, 50 (4): 1463-9. 10.1128/AAC.50.4.1463-1469.2006PubMed CentralView ArticlePubMedGoogle Scholar
- Koo H, Rosalen PL, Cury JA, Park YK, Bowen WH: Effects of compounds found in propolis on Streptococcus mutans growth and on glucosyltransferase activity. Antimicrob Agents Chemother. 2002, 46 (5): 1302-9. 10.1128/AAC.46.5.1302-1309.2002PubMed CentralView ArticlePubMedGoogle Scholar
- Semighini CP, Murray N, Harris SD: Inhibition of Fusarium graminearum growth and development by farnesol. FEMS Microbiol Lett. 2008, 279 (2): 259-64. 10.1111/j.1574-6968.2007.01042.xView ArticlePubMedGoogle Scholar
- Brehm-Stecher BF, Johnson EA: Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone. Antimicrob Agents Chemother. 2003, 47 (10): 3357-60. 10.1128/AAC.47.10.3357-3360.2003PubMed CentralView ArticlePubMedGoogle Scholar
- Jabra-Rizk MA, Shirtliff M, James C, Meiller T: Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance. FEMS Yeast Res. 2006, 6 (7): 1063-73. 10.1111/j.1567-1364.2006.00121.xView ArticlePubMedGoogle Scholar
- Hornby JM, Jensen EC, Lisec AD, Tasto JJ, Jahnke B, Shoemaker R, Dussault P, Nickerson KW: Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol. 2001, 67 (7): 2982-92. 10.1128/AEM.67.7.2982-2992.2001PubMed CentralView ArticlePubMedGoogle Scholar
- Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL: Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol. 2002, 68 (11): 5459-63. 10.1128/AEM.68.11.5459-5463.2002PubMed CentralView ArticlePubMedGoogle Scholar
- Hornby JM, Kebaara BW, Nickerson KW: Farnesol biosynthesis in Candida albicans: cellular response to sterol inhibition by zaragozic acid B. Antimicrob Agents Chemother. 2003, 47 (7): 2366-9. 10.1128/AAC.47.7.2366-2369.2003PubMed CentralView ArticlePubMedGoogle Scholar
- Navarathna DH, Hornby JM, Krishnan N, Parkhurst A, Duhamel GE, Nickerson KW: Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans. Infect Immun. 2007, 75 (4): 1609-18. 10.1128/IAI.01182-06PubMed CentralView ArticlePubMedGoogle Scholar
- Semighini CP, Hornby JM, Dumitru R, Nickerson KW, Harris SD: Farnesol-induced apoptosis in Aspergillus nidulans reveals a possible mechanism for antagonistic interactions between fungi. Mol Microbiol. 2006, 59 (3): 753-64. 10.1111/j.1365-2958.2005.04976.xView ArticlePubMedGoogle Scholar
- Rossignol T, Logue ME, Reynolds K, Grenon M, Lowndes NF, Butler G: Transcriptional response of Candida parapsilosis following exposure to farnesol. Antimicrob Agents Chemother. 2007, 51 (7): 2304-12.PubMed CentralView ArticlePubMedGoogle Scholar
- Franco M: Host-parasite relationships in paracoccidioidomycosis. J Med Vet Mycol. 1987, 25 (1): 5-18. Review. 10.1080/02681218780000021View ArticlePubMedGoogle Scholar
- Restrepo A: The ecology of Paracoccidioides brasiliensis: a puzzle still unsolved. Sabouraudia. 1985, 23 (5): 323-34.View ArticlePubMedGoogle Scholar
- Restrepo A, McEwen JG, Castaneda E: The habitat of Paracoccidioides brasiliensis: how far from solving the riddle?. Med Mycol. 2001, 39 (3): 233-41. 10.1080/714031028View ArticlePubMedGoogle Scholar
- San-Blas G, Niño-Vega G, Iturriaga T: Paracoccidioides brasiliensis and paracoccidioidomycosis: molecular approaches to morphogenesis, diagnosis, epidemiology, taxonomy and genetics. Med Mycol. 2002, 40 (3): 225-42. 10.1080/714031110View ArticlePubMedGoogle Scholar
- Goihman-Yahr M, Pine L, Albornoz MC, Yarzabal L, de Gomez MH, San Martin B, Ocanto A, Molina T, Convit J: Studies on plating efficiency and estimation of viability of suspensions of Paracoccidioides brasiliensis yeast cells. Mycopathologia. 1980, 71 (2): 73-83. 10.1007/BF00440612View ArticlePubMedGoogle Scholar
- Carrillo-Muñoz AJ, Giusiano G, Ezkurra PA, Quindós G: Antifungal agents: mode of action in yeast cells. Rev Esp Quimioter. 2006, 19 (2): 130-9.PubMedGoogle Scholar
- Chakrabarti A: Microbiology of systemic fungal infections. J Postgrad Med. 2005, 51 (Suppl 1): S16-20.PubMedGoogle Scholar
- Gupta AK, Tomas E: New antifungal agents. Dermatol Clin. 2003, 21 (3): 565-76. 10.1016/S0733-8635(03)00024-XView ArticlePubMedGoogle Scholar
- Hahn RC, Fontes CJ, Batista RD, Hamdan JS: In vitro comparison of activities of terbinafine and itraconazole against Paracoccidioides brasiliensis. J Clin Microbiol. 2002, 40 (8): 2828-31. 10.1128/JCM.40.8.2828-2831.2002PubMed CentralView ArticlePubMedGoogle Scholar
- Kauffman CA: Fungal infections. Proc Am Thorac Soc. 2006, 3 (1): 35-40. 10.1513/pats.200510-110JHView ArticlePubMedGoogle Scholar
- Hahn RC, Morato-Conceição YT, Santos NL, Ferreira JF, Hamdan JS: Disseminated paracoccidioidomycosis: correlation between clinical and in vitro resistance to ketoconazole and trimethoprim sulphamethoxazole. Mycoses. 2003, 46 (8): 342-7. 10.1046/j.1439-0507.2003.00901.xView ArticlePubMedGoogle Scholar
- Costa CS, Albuquerque FC, Andrade RV, Oliveira GC, Almeida MF, Brigido MM, Maranhão AQ: Transporters in the Paracoccidioides brasiliensis transcriptome: insights on drug resistance. Genet Mol Res. 2005, 4 (2): 390-408.Google Scholar
- San-Blas G, San-Blas F, Gil F, Mariño L, Apitz-Castro R: Inhibition of growth of the dimorphic fungus Paracoccidioides brasiliensis by ajoene. Antimicrob Agents Chemother. 1989, 33 (9): 1641-4.PubMed CentralView ArticlePubMedGoogle Scholar
- San-Blas G, Urbina JA, Marchán E, Contreras LM, Sorais F, San-Blas F: Inhibition of Paracoccidioides brasiliensis by ajoene is associated with blockade of phosphatidylcholine biosynthesis. Microbiology. 1997, 143 (Pt 5): 1583-6.View ArticlePubMedGoogle Scholar
- Thomaz L, Apitz-Castro R, Marques AF, Travassos LR, Taborda CP: Experimental paracoccidioidomycosis: alternative therapy with ajoene, compound from Allium sativum, associated with sulfamethoxazole/trimethoprim. Med Mycol. 2008, 46 (2): 113-8. 10.1080/13693780701651681View ArticlePubMedGoogle Scholar
- Palá-Paúl J, Brophy JJ, Pérez-Alonso MJ, Usano J, Soria SC: Essential oil composition of the different parts of Eryngium corniculatum Lam. (Apiaceae) from Spain. J Chromatogr A. 2007, 1175 (2): 289-93. 10.1016/j.chroma.2007.10.061View ArticlePubMedGoogle Scholar
- Dionigi CP, Millie DF, Johnsen PB: Effects of farnesol and the off-flavor derivative geosmin on Streptomyces tendae. Appl Environ Microbiol. 1991, 57 (12): 3429-32.PubMed CentralPubMedGoogle Scholar
- Machida K, Tanaka T, Fujita K, Taniguchi M: Farnesol-induced generation of reactive oxygen species via indirect inhibition of the mitochondrial electron transport chain in the yeast Saccharomyces cerevisiae. J Bacteriol. 1998, 180 (17): 4460-5.PubMed CentralPubMedGoogle Scholar
- Machida K, Tanaka T, Yano Y, Otani S, Taniguchi M: Farnesol induced growth inhibition in Saccharomyces cerevisiae by a cell cycle mechanism. Microbiology. 1999, 145 (Pt 2): 293-9.View ArticlePubMedGoogle Scholar
- Uppuluri P, Mekala S, Chaffin WL: Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue. Yeast. 2007, 24 (8): 681-93. 10.1002/yea.1501View ArticlePubMedGoogle Scholar
- Mosel DD, Dumitru R, Hornby JM, Atkin AL, Nickerson KW: Farnesol concentrations required to block germ tube formation in Candida albicans in the presence and absence of serum. Appl Environ Microbiol. 2005, 71 (8): 4938-40. 10.1128/AEM.71.8.4938-4940.2005PubMed CentralView ArticlePubMedGoogle Scholar
- Cugini C, Calfee MW, Farrow JM, Morales DK, Pesci EC, Hogan DA: Farnesol, a common sesquiterpene, inhibits PQS production in Pseudomonas aeruginosa. Mol Microbiol. 2007, 65 (4): 896-906. 10.1111/j.1365-2958.2007.05840.xView ArticlePubMedGoogle Scholar
- Derengowski LS, Mello-de-Sousa TM, Kyaw CM, Silva-Pereira I: Is there molecular communication between Candida albicans and Paracoccidioides brasiliensis? [abstract]. XXXVI Annual Meet of the Brazilian Soc for Biochem and Mol Biol. 2007, G-32: SBBq. Salvador, Brazil.Google Scholar
- Chen H, Fujita M, Feng Q, Clardy J, Fink GR: Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci USA. 2004, 101 (14): 5048-5052. 10.1073/pnas.0401416101PubMed CentralView ArticlePubMedGoogle Scholar
- Akiyama H, Oono T, Huh WK, Yamasaki O, Ogawa S, Katsuyama M, Ichikawa H, Iwatsuki K: Actions of farnesol and xylitol against Staphylococcus aureus. Chemoterapy. 2002, 48 (3): 122-8. 10.1159/000064916.View ArticleGoogle Scholar
- Voziyan PA, Goldner CM, Melnykovych G: Farnesol inhibits phosphatidylcholine biosynthesis in cultured cells by decreasing cholinephosphotransferase activity. Biochem J. 1993, 295 (Pt 3): 757-62.PubMed CentralView ArticlePubMedGoogle Scholar
- Miquel K, Pradines A, Tercé F, Selmi S, Favre G: Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells. J Biol Chem. 1998, 273 (40): 26179-86. 10.1074/jbc.273.40.26179View ArticlePubMedGoogle Scholar
- Brummer E, Sun SH, Harrison JL, Perlman AM, Philpott DE, Stevens DA: Ultrastructure of phagocytosed Paracoccidioides brasiliensis in nonactivated or activated macrophages. Infect Immun. 1990, 58 (8): 2628-36.PubMed CentralPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.